Peroral therapy with cytosine arabinoside. Preliminary laboratory and clinical findings.
D000368:Aged; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects; D003110:Colonic Neoplasms / Q000188:drug therapy*; D006224:Cricetinae; D003561:Cytarabine / Q000627:therapeutic use*; D004938:Esophageal Neoplasms / Q000188:drug therapy; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009374:Neoplasms, Experimental / Q000188:drug therapy; D012004:Rectal Neoplasms / Q000188:drug therapy; D013274:Stomach Neoplasms / Q000188:drug therapy
D003561:Cytarabine